Abstract
As key components of cellular regulation and signal transduction, eukaryotic protein kinases (EPKs) are strictly regulated. Sophisticated control mechanisms of EPKs are necessary which typically include conformational changes of the enzymes in critical regions. Local structural plasticity is therefore a prerequisite of normal EPK function. Protein kinase CK2, a member of the CMGC family of EPKs, was regarded as an exception from this rule for a long time due to its constitutive activity (lack of an inactive state) and due to its structural rigidity in typical EPK control regions of its catalytic subunit CK2α like the activation segment and the helix αC. Gradually, however, several cases of inherent local plasticity within CK2α were detected, and questions about their crosstalk and their functional significance became an issue. It is very likely now that structural plasticity and dynamics is more important for CK2 function than believed previously. Novel interpretation methods of crystallographic data even confirm an allosteric communication between the ATP site and CK2β-binding site of CK2α which had been only hypothetically postulated before. Similarly, local mobilities of CK2α are subject to modern computational approaches suggesting conformational equilibria in solution as assumed previously. In summary, CK2 structural biology has reached now a mature phase in which sophisticated modern techniques overcome the limitations of classical crystallography so that structural dynamics rather than single “snapshots” is investigated.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Protein kinase CK2
- Casein kinase 2
- Eukaryotic protein kinases
- CMGC kinases
- Signal transduction pathways
- Structural plasticity
- Structural dynamics
- Constitutive activity
- Hinge region
- Allosteric communication
1 CK2: A Protein Kinase of Limited Internal Mobility
“Conformational plasticity” as a basis of regulation and functional control was described as a hallmark of eukaryotic protein kinases (EPKs) more than a decade ago [1]. In recent reviews, this feature received particular attention and emphasis: EPKs were referred to as “dynamic molecular switches” [2] or as “allosteric macromolecular switches” [3] that received plasticity-correlated regulatability during evolution in contrast to similarly folded but more simple small-molecule kinases [4]. In particular, EPKs acquired an activation segment as part of their C-terminal domains (C-lobes) [4]. This activation segment is often the subject of (auto)phosphorylation and adapt able in its conformational state [1, 4], and it is assisted in this regulatorily relevant plasticity by the helix αC, the main control element of the N-terminal domain (N-lobe). Apart from regulation, large conformational changes within EPKs were also discussed to be necessary steps within the catalytic cycle itself [5].
Against this background, protein kinase CK2—a heterotetrameric complex of two catalytic chains (CK2α) attached to an obligatory homodimer of regulatory subunits (CK2β)[6]—was (and essentially still is) regarded as an apparent exception: it is no subject of regulatory phosphorylation at the activation segment of CK2α and does not dispose of a clearly defined inactive state. On a structural level, this “constitutive activity” was underpinned by a remarkable conformational rigidity of the activation segment and the helix αC. Both of them are fixed by the likewise structurally invariant N-terminal segment of CK2α via intramolecular interactions that resemble functionally the intermolecular contacts of the cyclin proteins with their corresponding cyclin-dependent kinases [7].
In the first review on CK2 structural biology published in 2009 [8], the structural conservation of the ensemble of activation segment, helix αC and N-terminal segment was emphasised by systematic structural comparisons including all 46 CK2α structures published at that time. The same analysis, however, illustrated that there are zones of structural variability as well (Fig. 1), some of them are typical loop regions in which flexibility is not unusual; others are with a clear conformational consensus among EPKs so that the plasticity discovered in CK2α (however not in all CK2α orthologues [9]) came as a surprise.
In subsequent years—with increasing numbers of structures—the picture of CK2 as an enzyme being conformationally constrained, where other EPKs are adaptable, but simultaneously disposing of regions of unusual adaptability, intensified and was addressed in a number of original and review publications [10–15], among them a recent metadynamics study to investigate conformational states separated by fairly high energy barriers [16]. Therefore, the local conformational and configurational variability of CK2 was the main subject of our contributions to the 7th International Conference on Protein Kinase CK2 in September 2013 in Lublin, Poland.
2 Indicators and Study Methods of Structural Plasticity
Basically, X-ray crystallography is of limited use for the investigation of conformational dynamics in proteins because the crystalline state of a protein requires and causes strong restraints on atomic mobility. However, some phenomena and approaches are able to relativise these restrictions:
-
B-factors: even under crystalline conditions, the individual atoms retain a certain degree of mobility. In crystallographic refinement, it is taken into account by the so-called B-factor, also known as the atomic temperature factor. The B-factor of an atom is proportional to the square of its mean displacement, i.e. a (hypothetical) ideally frozen atom has a B-factor of 0 while strong mobility correlates with high B-factors. Noteworthy, these B-factors reflect the inherent mobilities of the proteins and are no crystal-packing artefacts [17]. In Fig. 1, regions of human CK2α with high B-factors are illustrated by thick tubes and red colour.
-
Polymorphism: many proteins crystallise in different crystal forms so that several snapshots of the conformational space are captured. This phenomenon is even enhanced by a sort of “functional polymorphism”, i.e. the fact that the protein can exist and can be crystallised in different functional states, e.g. in complex with various ligands like substrates, inhibitors or other interaction partner. Recent CK2-related examples for a systematic investigation of structural polymorphism are the works of Papinutto et al. [14] and of Klopffleisch et al. [15].
-
Starting from one or several experimentally determined conformations, computational methods (molecular dynamics) can be used to explore the conformational space quite efficiently and to expand in this way the structure-based understanding. A valuable example of this approach in the case of CK2 was published by Gouron et al. [16].
-
In recent years, sophisticated methods were developed to regard a protein crystal structure even more than just as a “snapshot”, but to derive conformational dynamic information directly from the (properly calculated and scaled) electron densities [18, 19]. In this context, room-temperature crystallography might experience a revival [20].
3 In Front of and Behind the β4β5 Loop
The β4β5 loop is a mobile structure element of CK2α with particularly high temperature factors (blue ellipse in Fig. 1). Like other EPKs [21], it harbours a hydrophobic surface cavity at either side: the “N-lobe cap” [21] and the “PIF pocket” [22] (Fig. 2). The plasticity of the β4β5 loop correlates with the occupation states of these two cavities.
3.1 The PIF-Pocket Region of CK2α Is Intramolecularly Plugged by an Absolutely Conserved Trp Side Chain
The intimate hook-up of the N-terminal segment with the helix αC and activation segment was the most conspicuous feature of the first CK2α structure [7]. It inspired Sarno et al. [23] to investigate the importance of the N-terminal segment by a set of point and N-terminal deletion mutants of human CK2α. Remarkably, the mutants CK2αΔ2-24 and CK2αΔ2-30 were inactive, but catalytic activity was partially rescued by CK2β [23].
Sarno et al.’s [23] results show that an active conformation of the helix αC and the activation segment does not absolutely depend on a network of contacts to the N-terminal segment but can be stabilised by CK2β as well. How CK2β manages this is not understood, in particular, since the CK2 holoenzyme structure (Fig. 3a) [6] revealed that CK2β does not directly touch the helix αC and the activation segment.
Recent observations with CK2α’ [24, 25], however, and unpublished mutational data from our group suggest that the rescue effect of CK2β on CK2αΔ2-24 and CK2αΔ2-30 might have to do with the PIF pocket [22] of CK2α. “PIF” means“PDK1 interacting fragment”. PIF is a region within enzymes of a certain AGC kinase subfamily which are phosphorylated and activated by 3-phosphoinositide-dependent protein kinase 1 (PDK1). The PIF fragment of these enzymes binds to PDK1’s PIF pocket providing thus the prime example for an external occupation of the PIF pocket. The global analysis of Thompson et al. [21] revealed a more general relevance of the PIF pocket for EPKs: it is a hydrophobic surface cavity that can be used for docking of intra- or intermolecular peptide regions for the purpose of substrate recruitment or activation, the latter being caused by the stabilisation of the adjacent helix αC in its active conformation.
In the case of CK2α, the PIF pocket is mainly occupied by the side chain of a tryptophan residue which is absolutely conserved among all CK2α sequences reported so far (Trp33 of human CK2α, Fig. 2). This Trp side chain can be plugged into the PIF pocket very deeply (PIF closed), as it is the case in the two human CK2α’ structures published to date [24, 25], or it can be located a bit more outside as found in most other CK2α structures (PIF open). So far, human CK2α is the only CK2α orthologue to be found with both extreme positions of Trp33 (Fig. 2). It may be possible to replace Trp33 completely from the PIF pocket by suitable small molecules and with consequences for the enzyme that are difficult to predict. Changing Trp33 to alanine in human CK2α has nearly no effect on the K M value for ATP and the k cat value for the kinase reaction with an artificial peptide substrate; however, the Trp33Ala mutant was significantly more susceptible to activation by CK2β (J. Hochscherf, A. Köhler, unpublished data) which resembles the behaviour of the mutants CK2αΔ2-24 and CK2αΔ2-30 observed by Sarno et al. [23].
3.2 The “N-Lobe Cap” of CK2α Coordinates CK2β and Serves as a Mobile Hinge of the CK2α/CK2β Interaction
The “N-lobe cap”, i.e. the front cavity of the β4β5 loop in EPKs [21], is a prominent functional site of CK2α since it serves for docking of CK2β via the primary CK2α/CK2β interaction [6] (Fig. 3a). CK2β binding to CK2α is an enthalpically driven process [26] that requires the β4β5 loop in an extended (“open”) conformation (Fig. 2), whereas in CK2β-unbound form the β4β5 loop can switch to a closed state [27, 28]. The closed β4β5 loop partly occupies the “N-lobe cap” cavity (Fig. 2) and contributes to the coordination of small molecules with a certain CK2β-antagonistic effect [29]. For coordination of peptidic CK2β competitors, however, the β4β5 loop has to be open like in the CK2 holoenzyme as recently shown in the complex structure of human CK2α1-335 with a cyclic peptide (Fig. 4a) [30].
But not only the β4β5 loop itself has conformational plasticity depending on the occupation state of its neighbouring cavities and the crystalline environment. Rather, already the first CK2α2β2 holoenzyme structure (Fig. 3a) [6] revealed that the whole primary CK2α/CK2β interaction is not rigid but adaptable. The structure originated from a hexagonal crystal packing in which the CK2α2β2 tetramers associate to trimeric rings (Fig. 3c) [31]. To fit into this arrangement, the two CK2α chains are attached in significantly different orientations to the CK2β dimer (Fig. 3b). This asymmetry is no inherent property of the CK2α2β2 holoenzyme; rather, in two recent studies with CK2α2β2 tetramers in monoclinic crystalline environments, the twofold symmetry of the CK2α2β2 holoenzyme is well preserved [32, 33]. Thus, three different orientations of the CK2β dimer relative to CK2α are known to date (Fig. 3b) providing the impression that the N-lobe cap cavity acts like a hinge to permit adaptability and mobility to a certain degree.
Whether and how these observations can be functionally interpreted is a subject of debate. While Lolli et al. [32] regarded the higher symmetrical form of the CK2α2β2 tetramer per se as the CK2 state of maximum activity, we emphasised the adaptability of the primary CK2α/CK2β contact as a prerequisite of the CK2α2β2 holoenzyme’s propensity to integrate into ring-like [31] or linear [33] higher-molecular aggregates (Fig. 3c/d) of reduced activity. The ensembles illustrated in Fig. 3c/d were found in two different crystal forms, but linear and ring-like states of the CK2 holoenzyme exist in solution as well where they are strongly effected by the concentration of salts and of polycationic substances [34]. This downregulatory aggregation propensity is such a prominent feature of the CK2 holoenzyme that it inspired Poole et al. [35] to classify CK2 as a “constitutively inactive” kinase.
4 Proline Cis-/Trans-Isomerisation at the β3αC Loop
The preferred configuration of a peptide bond with its partial double bond character is trans, but cis-/trans-isomerisation of peptide bonds is a well-known phenomenon, in particular if proline provides the amide nitrogen atom [36]. Since the process requires breaking of a (partial) double bond, it is by definition a change of the configuration rather than the conformation as it is incorrectly designated in many publications. Cis-/trans-isomerisation in polypeptide chains often occurs as part of the protein folding process; CK2α, e.g., always contains a stable cis-peptide, namely, in a loop region of its C-terminal helical domain (Pro231 of human CK2α). With one cis-peptide among 17 proline residues, the cis-proline frequency in human CK2α is close to the average determined from a data set of 571 nonredundant protein structures [37].
Yet, cis-/trans-isomerisation happens in mature proteins as well where it is assumed to be an “intrinsic molecular switch” [38] without the need for covalent modifications. Often special enzymes—the peptidyl prolyl isomerases—are required to enable and control the process which is sometimes dependent on the phosphorylation of a neighbouring side chain and which is regarded as an important “molecular timer” [39]. In addition, enzyme-independent “native state proline isomerisation” [38] was observed and is likely to be functionally relevant.
In summary, there is an amazingly large literature about both enzyme-catalysed and spontaneous cis-/trans-plasticity at prolyl peptide bonds. Against this background, it was less surprising than we believed when we recently identified a so far unknown cis-proline in the N-terminal domain of CK2α (PDB 4IB5, Fig. 4b) [30]. More precisely, it was found at Pro72 within the β3αC loop (magenta-coloured ellipse of Fig. 1) of human CK2α1-335. In all previous CK2α structures, a trans-proline had been observed at this position. Noteworthy, the preparation procedure involving bacterial gene expression and chromatographic purification did not significantly differ.
The functional meaning of a cis-/trans-plasticity at Pro72 is unclear so far. Pro72 is an absolutely conserved residue of CK2α, and the β3αC loop of CK2α is unconventional among EPKs because of its shortness missing the helix αB of the canonical protein kinase fold [40]. The aforesaid structure [30] suggested a correlation with the occupation of the N-lobe cap by a cyclic peptide mimicking the binding region of CK2β, since only with the cis-configuration at Pro72 the preceeding Lys71 side chain could form a hydrogen bond with a critical tyrosine side chain of the cyclic peptide (Fig. 4b). To probe the hypothesis that Pro72 and its ability to switch to the cis-configuration play a role in binding of the cyclic peptide or even CK2β, we created a point mutant Pro72Ala of CK2α1-335. Preliminary and unpublished data of this mutant show no significant changes in the binding profile. Unexpectedly, however, it was thermostabilised and folded much more efficiently in the bacterial expression system than the wild type.
5 The Hinge/Helix αD Region: A Case of “Cracking”?
The interdomain hinge/helix αD region of CK2α (green ellipse in Fig. 1, Fig. 5) has two remarkable features otherwise unknown from EPKs:
-
The predominant conformation of this zone is different from other EPKs, leaving more space at the ATP-binding site and contributing thus to the “dual-cosubstrate specificity” of the enzyme [41, 42]. This fact was already discussed in the first structure publication of CK2α [7] when only a handful of comparison structures were available, but it received a more profound basis by the spine concept of Taylor and Kornev [4] according to which any fully active protein kinase requires two “spines”, i.e. two stacks of hydrophobic side chains crossing the interdomain interface. Consistent to this concept, CK2α has a “regulatory spine” which was never observed in a disassembled state, but Taylor and Kornev [4] left CK2α out when they illustrated the second, the “catalytic spine”, which includes a side chain from the hinge/helix αD region. In other words, with respect to the regulatory spine, CK2α is a perfect representative of a typical EPK, but concerning the catalytic spine, it is an outlier [12, 13] (magenta-coloured trace in Fig. 5a) and once again a “challenge to canons” [43].
-
The hinge/helix αD region of CK2α is not always stable in its non-canonical conformation; rather, it can switch to the EPK-canonical catalytic spine state (green trace in Fig. 5a). This conformational plasticity was noticed first in 2005 [42] and presented to the community at the 5th International Conference on Protein Kinase CK2 in 2007 in Padua, Italy, where it was discussed in the light of the protein kinase pharmacophore model of Traxler and Furet [44] (Fig. 5b). In 2008, the first report published [9] that CK2α orthologues differ in this respect: while maize CK2α sticks to the non-canonical and space-providing “open” hinge/helix αD conformation (Fig. 5a/b), human CK2α is able to exist with the EPK-typical “closed” conformation as well.
A number of follow-up questions were addressed in the subsequent years: (1) Which internal or external restraints and in particular which ligands favour either the open or the closed hinge/helix αD conformation? (2) Why do some CK2α orthologues exist always and stably with an open hinge/helix αD conformation while others can switch to the closed state? (3) Which of the two conformations is the (more) active one? (4) Can the particular features of the hinge/helix αD region be exploited for the design of CK2α-targeting drug, i.e. for improving the selectivity by addressing the unique open conformation? (5) Is the plasticity of the hinge/helix αD region coupled to the flexibility of other regions like the β4β5 loop or the ATP-binding loop?
One of the problems in this context became recently apparent by an analysis in which we described a strong artificial influence of the crystallisation conditions on the conformation of the hinge/helix CK2α region [15]: CK2α structures going back to crystallisation media dominated by kosmotropic salts like ammonium sulphate or sodium citrate as precipitants always have the “closed” hinge/helix αD conformation; this makes sense insofar as kosmotropic salts typically support hydrophobic interactions which means in this context that they induce the completion of the hydrophobic catalytic spine by burying the otherwise solvent-exposed aromatic side chain of Phe121 in a hydrophobic cavity formed by the other catalytic spine side chains (Fig. 5a). In other words, whenever CK2α was crystallised by a kosmotropic salt as a salting-out agent, the hinge/helix αD region is dominated by this medium and adopts the EPK-canonical conformation irrespective of any ligand. Noteworthy, maize CK2α that seems to have particular sequence adaptations in this region in favour of the open hinge/helix αD conformation [12] was never crystallised by a kosmotropic salt.
Hence, it is not trivial to distinguish between such artificial restraints on the hinge/helix αD conformation and genuine effects of ATP-competitive ligands. Nevertheless, Battistutta and Lolli [12] derived a rule that can be regarded as well established now: ATP-site ligands without polar interactions to the backbone of the hinge region (e.g. the inhibitor emodin [9, 14, 27]) do not prefer either of the two conformations, whereas ligands that exploit such hinge interactions for binding (like ATP as the prototype) have a clear preference for the open hinge/helix αD conformation.
CK2β was a further ligand of CK2α suspected to be capable of stabilising the open hinge/helix αD conformation [11]. This hypothesis was based on the first CK2α2β2 holoenzyme structure [6] in which both CK2α chains have an open hinge/helix αD conformation, but due to the non-proximity of CK2β and the hinge/helix αD region, it lacked a convincing mechanistic rationale. In fact, recent CK2α2β2 tetramer [32] and CK2α/cyclic peptide structures [30] with closed hinge/helix αD conformation ruled out the notion that the occupation of CK2α’s N-lobe cap by CK2β or by a CK2β analogue induces the open hinge/helix αD conformation.
Recent molecular dynamic simulations have revealed that the closed hinge/helix αD conformation is energetically even more stable than the open one [16]. The highest activation energy barrier between the two states is about 33.5 kJ/mol and depends largely on the rotation of the aforementioned Phe121 side chain (Fig. 5a) [16]. This is consistent with stable populations in solution coexisting in a dynamic equilibrium and with the possibility to stabilise either of them by specific ligands.
In many human CK2α structures, however, the whole hinge/helix αD region is characterised by a high degree of disorder, i.e. by high crystallographic B-factors and disrupted electron density maps. Noteworthy, this zone is not a typical surface loop for which this kind of disorder is not unusual. Rather, it looks like an example of local protein unfolding or “cracking” [45], a phenomenon that is assumed to play a key role for the change of a protein between two functionally relevant states by lowering the activation barrier via entropy reduction. In the case of epithelial growth factor receptor kinase, molecular dynamic simulations accompanied by hydrogen/deuterium exchange studies suggested that cracking of the hinge/helix αD region is important for the transition to catalytically inactive conformations [46]. How general cracking of the hinge/helix αD region is for EPKs and in particular whether it plays a role in the function of CK2α is an open and a very interesting question.
6 The Glycine-Rich ATP-Binding Loop: The Classical Case of Structural Plasticity
Apart from the hinge/helix αD region, the ATP-binding loop, which connects the β-strands 1 and 2 and stabilises via highly conserved glycine residues the negatively charged triphospho moiety of the cosubstrate, is the second functionally important high-mobility zone (black ellipse in Fig. 1) investigated in the aforementioned molecular dynamics study [16]. The rationale for this selection was a model [11] according to which CK2β-unbound CK2α might exist in a dynamic equilibrium between three conformationally and functionally different states (Fig. 6a): (i) fully active with open hinge/helix αD region and stretched ATP-binding loop; (ii) fully inactive [10] with a closed hinge/helix αD region, with a collapsed ATP-binding loop blocking the ATP site and with a shortcut of both elements via an ionic interaction between Arg47 and Asp120; and (iii) partially active with a closed hinge/helix αD region but with a stretched ATP-binding loop so that binding of ATP is possible [42] albeit in a not fully productive way.
The computational study [16] confirmed that the two principal states of the ATP-binding loop (stretched and collapsed as illustrated in Fig. 6b) have approximately the same free energy. Although the highest activation barrier along the path between them is only about 13 kJ/mol, a spontaneous collapse of the stretched ATP-binding loop during a 40 ns calculation could not be observed [16]. Nevertheless, among CK2α crystal structures, a collapse of the ATP-binding loop [27] and in particular the bending down of Arg47 into the ATP site (Fig. 6b) were observed more than once. Most recently, it was found (at least in one of three CK2α chains unambiguously) in the complex structure of human CK2α with a cyclic CK2β-mimetic peptide [30].
Insofar the existence of CK2α conformations with a collapsed ATP-binding loop is assured. It is well possible that CK2β by touching the back of the β1/β2 region (Fig. 6c) [6, 32, 33]—noteworthy, Phe54 in strand β2 is one of the “hot spots” of the CK2α/CK2β interaction [47] as visible in Fig. 4a—activates CK2α by stabilising the stretched ATP-binding loop and by preventing Arg47 from blocking the access to the ATP site [10]. In accordance with this notion, a recent study, in which conformational dynamics was derived from a sophisticated redefinition of electron density noise level followed by a systematic analysis of concerted side chain movements in some structures of CK2α and other EPKs, has revealed such an allosteric communication pathway between the ATP site and the CK2β-binding site of CK2α [19] (Fig. 6d).
7 The CMGC-Typical αGH Insert Remains Puzzling in its Function
As a member of the CMGC family of EPKs [48], CK2α contains a CMGC-characteristic helical insertion between the helices αG and αH of the EPK consensus fold [40]. In all CK2α structures, this insert has high B-factors (red ellipse in Fig. 1). Five years ago, we developed some ideas about possible functions of this region in the context of substrate binding and recognition based on homology to other CMGC family EPKs [8]; none of those notions was confirmed since that time, but falsification did not happen either. So the function of this high-mobility region remains enigmatic. For more insight, structures of enzyme/substrate complexes have to be awaited.
8 CK2 Structural Biology: From Basic Insight to Application and Back!
After in an initial phase some fundamental CK2 structures had been published [6, 7, 49], CK2 crystallography entered an “application phase” already several years ago when CK2α/inhibitor structures became more and more important as valuable tools for drug development [50].While efforts in structure-based design of CK2 inhibitors is ongoing, the interest in the structural bases of fundamental properties of CK2 is revitalised. Aggregation and autoregulation phenomena of the CK2 holoenzyme are structurally investigated [31–33]; more species than so far are taken into account in CK2 structural biology [51]. We believe that more information about the conformational and configurational dynamics of the enzyme will enrich these efforts in a most fruitful way.
References
Huse M, Kuriyan J (2002) The conformational plasticity of protein kinases. Cell 109:275–282
Taylor SS, Keshwani MM, Steichen JM, Kornev AP (2012) Evolution of the eukaryotic protein kinases as dynamic molecular switches. Philos Trans R Soc Lond B Biol Sci 367:2517–2528
Taylor SS, Ilouz R, Zhang P, Kornev AP (2012) Assembly of allosteric macromolecular switches: lessons from PKA. Nat Rev Mol Cell Biol 13:646–658
Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36:65–77
Jura N, Zhang X, Endres NF, Seeliger MA, Schindler T, Kuriyan J (2011) Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol Cell 42:9–22
Niefind K, Guerra B, Ermakowa I, Issinger O-G (2001) Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J 20:5320–5331
Niefind K, Guerra B, Pinna LA, Issinger O-G, Schomburg D (1998) Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 Å resolution. EMBO J 17:2451–2462
Niefind K, Raaf J, Issinger O-G (2009) Protein kinase CK2: from structures to insights. Cell Mol Life Sci 66:1800–1816
Raaf J, Klopffleisch K, Issinger O-G, Niefind K (2008) The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin. J Mol Biol 377:1–8
Raaf J, Issinger O-G, Niefind K (2009) First inactive conformation of CK2α, the catalytic subunit of protein kinase CK2. J Mol Biol 386:1212–1221
Niefind K, Issinger O-G (2010) Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design. Biochim Biophys Acta 1804:484–492
Battistutta R, Lolli G (2011) Structural and functional determinants of protein kinase CK2α: facts and open questions. Mol Cell Biochem 356:67–73
Bischoff N, Raaf J, Olsen B, Bretner M, Issinger O-G, Niefind K (2011) Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α’. Mol Cell Biochem 356:57–65
Papinutto E, Ranchio A, Lolli G, Pinna LA, Battistutta R (2012) Structural and functional analysis of the flexible regions of the catalytic alpha-subunit of protein kinase CK2. J Struct Biol 177:382–391
Klopffleisch K, Issinger OG, Niefind K (2012) Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias. Acta Crystallogr D68:883–892
Gouron A, Milet A, Jamet H (2014) Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics. Biophys J 106:1134–1141
Artymiuk PJ, Blake CC, Grace DE, Oatley SJ, Phillips DC, Sternberg MJ (1979) Crystallographic studies of the dynamic properties of lysozyme. Nature 280:563–568
Lang PT, Ng HL, Fraser JS, Corn JE, Echols N, Sales M, Holton JM, Alber T (2010) Automated electron-density sampling reveals widespread conformational polymorphism in proteins. Protein Sci 19:1420–1431
Lang PT, Holton JM, Fraser JS, Alber T (2014) Protein structural ensembles are revealed by redefining X-ray electron density noise. Proc Natl Acad Sci U S A 111:237–242
Fraser JS, van den Bedem H, Samelson AJ, Lang PT, Holton JM, Echols N, Alber T (2011) Accessing protein conformational ensembles using room-temperature X-ray crystallography. Proc Natl Acad Sci U S A 108:16247–16252
Thompson EE, Kornev AP, Kannan N, Kim C, Ten Eyck LF, Taylor SS (2009) Comparative surface geometry of the protein kinase family. Protein Sci 18:2016–2026
Biondi RM, Cheung PC, Casamayor A, Deak M, Currie RA, Alessi DR (2000) Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J 19:979–988
Sarno S, Ghisellini P, Pinna LA (2002) Unique activation mechanism of protein kinase CK2: the N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme. J Biol Chem 277:22509–22514
Nakaniwa T, Kinoshita T, Sekiguchi Y, Tada T, Nakanishi I, Kitaura K, Suzuki Y, Ohno H, Hirasawa A, Tsujimoto G (2009) Structure of human protein kinase CK2α2 with a potent indazole-derivative inhibitor. Acta Crystallogr F65:75–79
Bischoff N, Olsen B, Raaf J, Bretner M, Issinger O-G, Niefind K (2011) Structure of the human protein kinase CK2 catalytic subunit CK2α’ and interaction thermodynamics with the regulatory subunit CK2β. J Mol Biol 407:1–12
Raaf J, Brunstein E, Issinger O-G, Niefind K (2008) The interaction of CK2α and CK2β, the subunits of protein kinase CK2, requires CK2β in a preformed conformation and is enthalpically driven. Protein Sci 17:2180–2186
Battistutta R, Sarno S, De Moliner E, Papinutto E, Zanotti G, Pinna LA (2000) The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. J Biol Chem 275:29618–29622
Ermakova I, Boldyreff B, Issinger O-G, Niefind K (2003) Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. J Mol Biol 330:925–934
Raaf J, Brunstein E, Issinger OG, Niefind K (2008) The CK2α/CK2β interface of human protein kinase CK2 harbors a binding pocket for small molecules. Chem Biol 15:111–117
Raaf J, Guerra B, Neundorf I, Bopp B, Issinger O-G, Jose J, Pietsch M, Niefind K (2013) First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand. ACS Chem Biol 8:901–907
Niefind K, Issinger O-G (2005) Primary and secondary interactions between CK2α and CK2β lead to ring-like structures in the crystals of the CK2 holoenzyme. Mol Cell Biochem 274:3–14
Lolli G, Ranchio A, Battistutta R (2014) Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture. ACS Chem Biol 9:366–371
Schnitzler A, Olsen BB, Issinger O-G, Niefind K (2014) The protein kinase CK2Andante holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation. J Mol Biol 426:1871–1882
Valero E, De Bonis S, Filhol O, Wade RH, Langowski J, Chambaz EM, Cochet C (1995) Quaternary structure of casein kinase 2. Characterization of multiple oligomeric states and relation with its catalytic activity. J Biol Chem 270:8345–8352
Poole A, Poore T, Bandhakavi S, McCann RO, Hanna DE, Glover CV (2005) A global view of CK2 function and regulation. Mol Cell Biochem 274:163–170
Craveur P, Joseph AP, Poulain P, de Brevern AG, Rebehmed J (2013) Cis-trans isomerization of omega dihedrals in proteins. Amino Acids 45:279–289
Jabs A, Weiss MS, Hilgenfeld R (1999) Non-proline cis peptide bonds in proteins. J Mol Biol 286:291–304
Andreotti AH (2003) Native state proline isomerization: an intrinsic molecular switch. Biochemistry 42:9515–9524
Lu KP, Finn G, Lee TH, Nicholson LK (2007) Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol 3:619–629
Knighton DR, Zheng JH, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS, Sowadski JM (1991) Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253:407–414
Niefind K, Pütter M, Guerra B, Issinger O-G, Schomburg D (1999) GTP plus water mimic ATP in the active site of protein kinase CK2. Nat Struct Biol 6:1100–1103
Yde CW, Ermakova I, Issinger OG, Niefind K (2005) Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate. J Mol Biol 347:399–414
Pinna LA (2002) Protein kinase CK2: a challenge to canons. J Cell Sci 115:3873–3878
Traxler P, Furet P (1999) Strategies toward the design of novel and selective protein tyrosine kinase inhibitors. Pharmacol Ther 82:195–206
Miyashita O, Onuchic JN, Wolynes PG (2003) Nonlinear elasticity, proteinquakes, and the energy landscapes of functional transitions in proteins. Proc Natl Acad Sci U S A 100:12570–12575
Shan Y, Arkhipov A, Kim ET, Pan AC, Shaw DE (2013) Transitions to catalytically inactive conformations in EGFR kinase. Proc Natl Acad Sci U S A 110:7270–7275
Raaf J, Bischoff N, Klopffleisch K, Brunstein E, Olsen BB, Vilk G, Litchfield DW, Issinger O-G, Niefind K (2011) Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface. Biochemistry 50:512–522
Niefind K, Yde CW, Ermakova I, Issinger O-G (2007) Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases. J Mol Biol 370:427–438
Chantalat L, Leroy D, Filhol O, Nueda A, Benitez MJ, Chambaz EM, Cochet C, Dideberg O (1999) Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization. EMBO J 18:2930–2940
Battistutta R (2009) Protein kinase CK2 in health and disease: structural bases of protein kinase CK2 inhibition. Cell Mol Life Sci 66:1868–1889
Liu H, Wang H, Teng M, Li X (2014) The multiple nucleotide-divalent cation binding modes of Saccharomyces cerevisiae CK2α indicate a possible co-substrate hydrolysis product (ADP/GDP) release pathway. Acta Crystallogr D70:501–513
The PyMOL Molecular Graphics System, Version 1.7, Schrödinger, LLC
Laudet B, Barette C, Dulery V, Renaudet O, Dumy P, Metz A, Prudent R, Deshiere A, Dideberg O, Filhol O, Cochet C (2007) Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction. Biochem J 408:363–373
Acknowledgement
The contributions of Anja Asendorf, Anna Köhler and Nicole Splett are gratefully acknowledged. The work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) to KNI (NI 643/4–1).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hochscherf, J., Schnitzler, A., Issinger, OG., Niefind, K. (2015). Impressions from the Conformational and Configurational Space Captured by Protein Kinase CK2. In: Ahmed, K., Issinger, OG., Szyszka, R. (eds) Protein Kinase CK2 Cellular Function in Normal and Disease States. Advances in Biochemistry in Health and Disease, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-14544-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-14544-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14543-3
Online ISBN: 978-3-319-14544-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)